Biology42: Generative Biologics

Platform

AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.

Find alternatives to Biology42: Generative Biologics

TypePlatform
RoleStandalone tool
AvailabilitySold
DeploymentSaaS
Intended for—
SecurityVendor-asserted
CertificationsISO/IEC 27001
Trains on customer dataUnknown
Zero data retentionUnknown
Data residencyCustom region
Security featuresEncryption at rest
StatusActive
Sold withinSold on its own
PricingEnterprise quote

What it does

Features 6

pharma.ai

Sources

Pricing

Official documentation · 3 Sep 2026

Contact-and-consultation model only. Page's own heading is 'Biology42: Generative Biologics'; suite nav shortens this to 'Generative Biologics'.

Constraints

Official documentation · 2 Oct 2026

Derived from the security facts on this page, from the same source.

Security

Official documentation · 2 Oct 2026

Company-wide Security & IT page covering client data and IP across engagements, applied to all listed products (page names none individually). ISO 27001 refers to the ISMS. Residency is client-chosen cloud servers, recorded as custom. Training, ZDR, DPA not stated.

Sold within

Official documentation · 15 Sep 2026

pharma.ai/generativebiologics (already cited official-docs elsewhere on this record); standalone technology access or combined with Pharma.ai collaborations, no restriction.

Also from Insilico Medicine

Open Insilico Medicine in the directory

Something wrong here? Send a correction — quote this product id: insilico-medicine-generative-biologics.